These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 31595639)
21. [Toxic hepatitis during the administration of ketoconazole (Nizoral)]. Kramer NJ; Montnor LP; Berghuis PH Ned Tijdschr Geneeskd; 1983 Feb; 127(8):343-4. PubMed ID: 6300703 [No Abstract] [Full Text] [Related]
22. Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature. Nikkels AF; Nikkels-Tassoudji N; Piérard GE Am J Clin Dermatol; 2006; 7(5):327-31. PubMed ID: 17007544 [TBL] [Abstract][Full Text] [Related]
24. Overview of the use of terbinafine (Lamisil) in children. Jones TC Br J Dermatol; 1995 May; 132(5):683-9. PubMed ID: 7772471 [TBL] [Abstract][Full Text] [Related]
25. [Terbinafine : Relevant drug interactions and their management]. Dürrbeck A; Nenoff P Hautarzt; 2016 Sep; 67(9):718-23. PubMed ID: 27474731 [TBL] [Abstract][Full Text] [Related]
26. [Hepatitis during the administration of ketoconazole (Nizoral)]. van Dijke CP Ned Tijdschr Geneeskd; 1983 Feb; 127(8):339-41. PubMed ID: 6300701 [No Abstract] [Full Text] [Related]
30. Dermatophytosis: the management of fungal infections. Gupta AK; Ryder JE; Chow M; Cooper EA Skinmed; 2005; 4(5):305-10. PubMed ID: 16282753 [TBL] [Abstract][Full Text] [Related]
34. [Terbinafine]. Bouyssou-Gauthier ML; Bonnetblanc JM Ann Dermatol Venereol; 1999 Jan; 126(1):81-9. PubMed ID: 10095904 [No Abstract] [Full Text] [Related]
35. Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts. Mallat A; Zafrani ES; Metreau JM; Dhumeaux D Dig Dis Sci; 1997 Jul; 42(7):1486-8. PubMed ID: 9246051 [TBL] [Abstract][Full Text] [Related]
36. [Acute hepatitis associated with terbinafine]. Vivas S; Rodríguez M; Palacio MA; Cadenas F; Lomo J; Rodrigo L Gastroenterol Hepatol; 1997 Nov; 20(9):456-8. PubMed ID: 9445740 [TBL] [Abstract][Full Text] [Related]
37. The safety and efficacy of terbinafine in patients with diabetes and patients who are HIV positive. Elewski B; Smith S Cutis; 2001 Jul; 68(1 Suppl):23-9. PubMed ID: 11499331 [TBL] [Abstract][Full Text] [Related]
38. Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails. Roberts DT Dermatology; 1997; 194 Suppl 1():37-9. PubMed ID: 9154400 [TBL] [Abstract][Full Text] [Related]
39. Clinical presentation of terbinafine-induced severe liver injury and the value of laboratory monitoring: a Critically Appraised Topic. Kramer ON; Albrecht J Br J Dermatol; 2017 Nov; 177(5):1279-1284. PubMed ID: 28762471 [TBL] [Abstract][Full Text] [Related]
40. Oral terbinafine (Lamisil) in the short-term treatment of fungal infections of the skin: results of a post-marketing surveillance study. Binder M; Nell G Mycoses; 1999; 42(9-10):555-8. PubMed ID: 10592700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]